Prevalence of antibiotic resistance among bacteria isolates of lower respiratory tract infection in COPD shahrekord - Iran, 2005

Pakistan Journal of Medical Sciences

Volumn 23, Issue 3, 2007, Pages 438-440

  Imani, Reza ^a   Rouhi, Hamid ^a   Ganji, Forouzan ^a  

^a SHAHREKORD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

COPD; Drug resistance; LRTIs

Indexed keywords

AMPICILLIN; ANTIINFECTIVE AGENT; CEFTRIAXONE; CIPROFLOXACIN; ERYTHROMYCIN; OFLOXACIN; PENICILLIN G;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL PNEUMONIA; BACTERIUM ISOLATE; BRONCHOSCOPY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DISEASE EXACERBATION; DRUG SENSITIVITY; HOSPITAL PATIENT; HUMAN; IN VITRO STUDY; INFLUENZA; IRAN; LOWER RESPIRATORY TRACT INFECTION; MAJOR CLINICAL STUDY; MORBIDITY; NONHUMAN; PREVALENCE;

EID: 34347375781     PISSN: 1682024X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Woodhead M. Community-acquired pneumonia guidelines an international comparison: A view from Europe. Chest 1998;113:1835-75.
2. Mandell LA, Marrie TJ, Grossman RF, Chow AW, Hyland RH. Canadian guidelines for the initial management of community-acquired pneumonia: An evidence-based update by the Canadian Infeious Diseases Society and the Canadian Thoracic Society. The Canadian community - acquired pneumonia working group Clin Infect Dis 2000;31:383-421.
3. Blasi F. Atypical pathogens and respiratory tract infections. Eur Respir J 2004;24:171-81.
4. Prescott E, Lange P, Vestbo J. Chronic mucus hypersectrtion in COPD and death from pulmonary infection. Eur Respir J 1995;8:1333-8.
5. Ball P, Tillotson G, Wilson R. Chemotherapy for chronic bronchitis controversies. La Presse Medicale 1995;24:189-94.
6. Murphy TF, Sethi S. Bacterial infection in chronic obstructive pulmonary disease. Am Rev Respir Dis 1992;146:1067-83.
7. Spika JF, Facklam RR, Plikaytis BD. Antimicrobial resistance of Streptococcus pneumoniae in the United States, 1979-1987. J Infect Dis 1991;163:1273-8.
8. Doern GV, Pfaller MA, Kugler K. Prevalence of antimicrobial resistance among respiratory tract isolates of Streptococcus pneumoniae in North America: 1997 results from the SENTRY antimicrobial surveillance program Clin Infect Dis 1998 ;27:764-70.
9. National Committee for Clinical Laboratory standards. Performance standards for antimicrobial susceptibility testing; 13th informational supplement 2003;23(1):M100-S13. National committee for clinical laboratory standards, Wayne, Pa.
10. National committee for clinical laboratory standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow acerbically: approved standard M7-A6, 6th ed, National committee for clinical laboratory standards, Wayne, Pa. 2003.
11. Song JH, Lee NY, Ichiyama S, Yoshida R, Hirakata Y, Fu W. Spread of Drug-Resistant Streptococcus pneumoniae in Asian Countries: Asian Network for surveillance of Resistant pathogens (ANSORP) study. Clinical Infectious Diseases 1999;28:1206-11.
12. Schito GC, Debbia EA, Marchese A. The evolving threat of antibiotic resistance in Europe: new data from the Alexaner project. J Antimicrob Chemother 2000;(46):TL,3-9.
13. Hsuch PR, Teng LJ, Lee LN, Yang PC, Ho SW, Lue HC, et al. Increased prevalence of erythromycin resistance in streptococci substantial upsurge in etythromycin resistant M phenotype in streptoccous pyogents (1979-1998) but not in streptococcus pneumoniae (1985-1999) in Taiwan. Nicrob. Drug Resist 2002;8:27-33.
14. Lyon IPMDJ, Yung RW, Chan C, Cheng AF. Macrolide resistance in streptococcus pneumoniae in Hong Kong Antimicrob. Agents chemother 2001;45:1578-80.
15. Kellner JD, Folrd-Jones EL, Toronto child care center study Group. Streptococcus pneumoniae carriage in children attending 59 Canadian child care centers. Arch Pediatr Adolesc Med 1999;153:495-502.
16. Boken DJ, Chartrand SA, Goering RV, Kruger R, Harrison CJ. Colonization with penicillin-resistant streptococcus pneumoniae in a child care center. Pediatr Infect Dis J 1995;14:879-84.
17. Thornsberry C, Ogilvie P, Kahn J. Surveillance of antimicrobial resistance in streptococcus pneumoniae , Haemophilus influenzae and Moraxella catarrhalis in the United states in 1996-1997 respiratory season. Lab Investi Group Diang Microbial infect Dis 1997;29:249-57.
18. Doern GV, Brueggemann AB, Pierce G. Prevalence of antimicrobial resistance among 723 outpatient clinical isolates of Moraxella catarrhalis in the United States in 1994 and 1995: results of a 30-center national surveillance study. Antimicrob Agents chemother 1996;40:2884-6.
19. Wilson R. Bacteia antibiotics and COPD. Eur Respir J 2001;17:995-1007.